as on September 16, 2025 at 1:29 am IST
Day's Low
Day's High
1.56%
Downside
2.19%
Upside
52 Week's Low
52 Week's High
36.86%
Downside
35.06%
Upside
Check Revolution Medicines Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$8.7B
EPS (TTM)
-5.2351
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-13.45
Industry PE ratio
10.127857142857144
P/B Ratio
0PEG Ratio
0EBITDA
-890.7M
Revenue (TTM)
742.0K
Profit Margin
0.00%
Return On Equity TTM
266062400.00%
Track how Revolution Medicines Inc P/E has moved over time to understand its valuation trends.
Revolution Medicines Inc in the last 5 years
Lowest (0.00x)
September 15, 2025
Today (-13.45x)
September 15, 2025
Industry (10.13x)
September 15, 2025
Highest (0.00x)
September 15, 2025
Today’s Price to Earnings Ratio: -13.45x
Compare market cap, revenue, PE, and other key metrics of Revolution Medicines Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $8.7B | 67.99% | -13.45 | 0.00% | |
BUY | $61.1B | 256.98% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $101.1B | 47.85% | 28.07 | 31.86% | |
BUY | $59.4B | -3.43% | 14.11 | 31.37% |
The Revolution Medicines Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Revolution Medicines Inc investment value today
Current value as on today
₹1,10,706
Returns
₹10,706
(+10.71%)
Returns from Revolution Medicines Inc Stock
₹5,721 (+5.72%)
Dollar Returns*
₹4,985 (+4.99%)
Based on 19 analysts
94.74%
Buy
5.26%
Hold
0.00%
Sell
Based on 19 analysts, 94.74% of analysts recommend a 'BUY' rating for Revolution Medicines Inc. Average target price of $75.41
Get share price movements and forecasts by analysts on Revolution Medicines Inc.
What analysts predicted
38.73%UPSIDE
Target Price
$75.41
Current Price
$46.2
Analyzed by
19 Analysts
Target
$75.41
Revolution Medicines Inc target price $75.41, a slight upside of 38.73% compared to current price of $46.2. According to 19 analysts rating.
Search interest for Revolution Medicines Inc Stock has increased by 400% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:400% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 11 September
Thu, 04:07 PM
-Wells Fargo raises Revolution Medicines price target to $70, citing positive trial data for daraxonrasib.
Thu, 09:08 PM
-Revolution Medicines stock surged 13% following positive trial data for daraxonrasib, with phase 3 trial planned.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, RVMD stock has moved up by 12.8%
Best in 3 Years
In the last 3 years, RVMD has outperformed top 5 stocks with highest market-cap in its industry
Revenue Rich
Revenue is up for the last 2 quarters, 742.0K → 261.59M (in $), with an average increase of 99.7% per quarter
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 66.9%
Profit Down
Netprofit is down for the last 6 quarters, -116.00M → -247.78M (in $), with an average decrease of 16.5% per quarter
Organisation | Revolution Medicines Inc |
Headquarters | 700 Saginaw Drive, Redwood City, CA, United States, 94063 |
Industry | Health Technology |
CEO | Dr. Mark A. Goldsmith M.D., Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Walter Reiher Ph.D. | Chief Information Officer |
Mr. Jack Anders | Chief Financial Officer |
Ms. Margaret A. Horn J.D. | Chief Operating Officer |
Dr. Martin D. Burke M.D., Ph.D. | Co-Founder & Chairman of Scientific Advisory Board |
Dr. Michael A. Fischbach Ph.D. | Academic Co-Founder & Member of Scientific Advisory Board |
Ms. Jan Smith Ph.D. | Chief Scientific Officer |
Dr. Mark A. Goldsmith M.D., Ph.D. | CEO, President & Chairman |
Dr. Stephen M. Kelsey FRC Path., FRCP, M.D. | President of Research & Development |
Ms. Xiaolin Wang | Executive Vice President of Development |
Dr. Kevan M. Shokat Ph.D. | Academic Co-Founder & Member of Scientific Advisory Board |
Revolution Medicines Inc share price today is $46.2 as on at the close of the market. Revolution Medicines Inc share today touched a day high of $47.21 and a low of $45.48.
Revolution Medicines Inc share touched a 52 week high of $62.4 on and a 52 week low of $29.17 on . Revolution Medicines Inc stock price today i.e. is closed at $46.2,which is 25.96% down from its 52 week high and 58.38% up from its 52 week low.
Revolution Medicines Inc market capitalisation is $0.01T as on .
Indian investors can start investing in Revolution Medicines Inc (RVMD) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Revolution Medicines Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Revolution Medicines Inc share’s latest price of $46.2 as on September 16, 2025 at 1:29 am IST, you will get 0.2165 shares of Revolution Medicines Inc. Learn more about
fractional shares .
Revolution Medicines Inc stock has given 67.99% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?